Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Malignant Lymphoma

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 13 articles:
HTML format



Single Articles


    June 2022
  1. LALIC H, Aurer I, Batinic D, Visnjic D, et al
    Bendamustine: A review of pharmacology, clinical use and immunological effects (Review).
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    March 2022
  2. KADOTA A, Moriguchi M, Watanabe T, Sekine Y, et al
    A pyridiniumtype fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of betacatenin.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    January 2022
  3. FRAZZI R, Cusenza VY, Pistoni M, Canovi L, et al
    KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    April 2021
  4. DUONG HQ, Than VT, Nguyen HT, Nguyen PT, et al
    Anaplastic lymphoma kinase inhibitor NVPTAE684 suppresses the proliferation of human pancreatic adenocarcinoma cells.
    Oncol Rep. 2021;45:1-11.
    PubMed     Abstract available


    January 2021
  5. XIE S, Fan W, Yang C, Lei W, et al
    Beclin1armed oncolytic Vaccinia virus enhances the therapeutic efficacy of RCHOP against lymphoma in vitro and in vivo.
    Oncol Rep. 2021 Jan 19. doi: 10.3892/or.2021.7942.
    PubMed     Abstract available


    December 2020
  6. FU J, Lou X, Wan S, Zhao X, et al
    microRNA196a3p inhibits cell proliferation and promotes cell apoptosis by targeting ADP ribosylation factor 4 in diffuse large Bcell lymphoma.
    Oncol Rep. 2020 Dec 16. doi: 10.3892/or.2020.7901.
    PubMed     Abstract available


  7. TAO HF, Shen JX, Hou ZW, Chen SY, et al
    lncRNA FOXP4AS1 predicts poor prognosis and accelerates the progression of mantle cell lymphoma through the miR4235p/NACC1 pathway.
    Oncol Rep. 2020 Dec 11. doi: 10.3892/or.2020.7897.
    PubMed     Abstract available


    November 2020
  8. GIBBS JD, Ma S, Kim A, Seminario-Vidal L, et al
    Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous Tcell lymphoma.
    Oncol Rep. 2020 Nov 23. doi: 10.3892/or.2020.7865.
    PubMed     Abstract available


  9. WANG L, Wang W
    Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in nonsmall cell lung cancer (Review).
    Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7851.
    PubMed     Abstract available


  10. ZHANG L, Zhou S, Zhou T, Yuan K, et al
    S100A8 promotes chemoresistance via augmenting autophagy in Bcell lymphoma cells.
    Oncol Rep. 2020 Nov 9. doi: 10.3892/or.2020.7841.
    PubMed     Abstract available


  11. ZHANG R, Zhu H, Yuan Y, Wang Y, et al
    SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma.
    Oncol Rep. 2020;44:2021-2030.
    PubMed     Abstract available


    October 2020
  12. KIM J, Kim JN, Park I, Sivtseva S, et al
    Dracocephalum palmatum Stephan extract induces caspase and mitochondriadependent apoptosis via Myc inhibition in diffuse large B cell lymphoma.
    Oncol Rep. 2020 Oct 8. doi: 10.3892/or.2020.7797.
    PubMed     Abstract available


    August 2020
  13. WU S, Zhang X, Dong M, Yang Z, et al
    sATPbinding cassette subfamily G member 2 enhances the multidrug resistance properties of human nasal natural killer/T cell lymphoma side population cells.
    Oncol Rep. 2020 Aug 10. doi: 10.3892/or.2020.7722.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: